Increasing Adherence to Pulmonary Rehabilitation After COPD Related Hospitalizations

Clinical Trial ID: NCT03865329


This study will look at the effectiveness of a home-based Pulmonary Rehabilitation Program in patients who have recently been hospitalized for a COPD related cause.

Despite proven benefits, the proportion of people with COPD who receive Pulmonary Rehabilitation (PR) is very small. The current model of a center-based PR program fails to address the needs of many patients with COPD. The most common patient barrier to attendance is travel to center-based programs, particularly for frail patients with more severe COPD who need transportation assistance. Home-based, unsupervised PR has been proposed as an alternative model to hospital-based programs and has been found to be safe and effective. In particular PR post-hospitalization has been reported as the most effective intervention to prevent a hospital readmission; however, the reality is that many times this is not a feasible intervention as only 4% of eligible individuals are able to adhere to PR after a hospital admission (for multiple reasons).While COPD is responsible for nearly 700,000 hospitalizations annually, many of these hospitalizations, which account for a large proportion of the annual direct medical costs of COPD, are potentially preventable readmissions. In this study we plan to add Health Coaching to PR to promote a behavior change to decrease COPD re-hospitalizations and sustainably improve QOL. We propose a simple system of Remote PR that may fill the practice gap.


Inclusion Criteria - COPD related hospitalization and eligible for PR - Exclusion Criteria - Inability to walk (orthopedic-neurologic problems or confined to bed)

  • Start Date


  • Last Updated


  • Sponsor

    National Heart, Lung, and Blood Institute (NHLBI)

  • Condition Name

    COPD Exacerbation

Learn about this trial.

Check the eligibility requirements, study details, and more.

Related Trials

Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.